Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix

Carcinogenesis

Volumn 31, Issue 2, 2010, Pages 311-317

  Sarkar, Susobhan ^a   Yong, V Wee ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; ISOENZYME; MACROPHAGE ELASTASE; PROTEIN KINASE C DELTA; SMALL INTERFERING RNA; TENASCIN;

ARTICLE; CANCER INVASION; CELL MEMBRANE; CELL STIMULATION; CONTROLLED STUDY; CYTOSOL; ENZYME INHIBITION; ENZYME SYNTHESIS; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEIN TRANSPORT; BRAIN TUMOR; CELL FRACTIONATION; CULTURE TECHNIQUE; DRUG ANTAGONISM; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; GLIOMA; IMMUNOPRECIPITATION; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL CULTURE TECHNIQUES; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; HUMANS; IMMUNOPRECIPITATION; NEOPLASM INVASIVENESS; PROTEIN KINASE C-DELTA; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; SUBCELLULAR FRACTIONS; TENASCIN; TUMOR CELLS, CULTURED;

EID: 77649209136     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp297     Document Type: Article

References (49)

1. Le, D.M. et al. (2003) Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. J. Neurosci., 23, 4034-4043.
2. Bellail, A.C. et al. (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int. J. Biochem. Cell Biol., 36, 1046-1069.
3. Rubenstein, B.M. et al. (2008) The role of extracellular matrix in glioma invasion: a cellular Potts model approach. Biophys J., 95, 5661-5680.
4. Goldbrunner, R.H. et al. (1998) ECM-mediated glioma cell invasion. Microsc. Res. Tech., 43, 250-257.
5. VanMeter, T.E. et al. (2001) The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J. Neurooncol., 53, 213-235.
6. Rao, J.S. (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer, 3, 489-501.
7. Park, M.H. et al. (2009) Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways. Carcinogenesis, 30, 356-365.
8. Sarkar, S. et al. (2009) Inflammatory cytokine modulation of matrix metalloproteinase expression and invasiveness of glioma cells in a 3-dimensional collagen matrix. J. Neurooncol., 91, 157-164.
9. Maris, C. et al. (2008) Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas. Neuropathol. Appl. Neurobiol., 34, 316-329.
10. Higuchi, M. et al. (1993) Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol., 85, 481-487.
11. Leins, A. et al. (2003) Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer, 98, 2430-2439.
12. Zagzag, D. et al. (1995) Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res., 55, 907-914.
13. Zamecnik, J. (2005) The extracellular space and matrix of gliomas. Acta Neuropathol., 110, 435-442.
14. Deryugina, E.I. et al. (1996) Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J. Cell Sci., 109, 643-652 (Pt 3).
15. Wang, F. et al. (1998) Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc. Natl Acad. Sci. USA, 95, 14821-14826.
16. Cukierman, E. et al. (2001) Taking cell-matrix adhesions to the third dimension. Science, 294, 1708-1712.
17. Hotary, K.B. et al. (2003) Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell, 114, 33-45.
18. Sarkar, S. et al. (2006) Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res., 66, 11771-11780.
19. Couldwell, W.T. et al. (1990) Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system. J. Neurosurg., 73, 594-600.
20. da Rocha, A.B. et al. (2002) Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas? Oncologist, 7, 17-33.
21. Sharif, T.R. et al. (1999) Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples. Int. J. Oncol., 15, 237-243.
22. Uhm, J.H. et al. (1996) Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clin. Exp. Metastasis, 14, 421-433.
23. Uht, R.M. et al. (2007) The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway. Oncogene, 26, 2885-2893.
24. Cho, K.K. et al. (1999) The role of protein kinase Calpha in U-87 glioma invasion. Int. J. Dev. Neurosci., 17, 447-461.
25. Esteve, P.O. et al. (2002) Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B. J. Biol. Chem., 277, 35150-35155.
26. Ali, A.S. et al. (2009) Exploitation of protein kinase C: a useful target for cancer therapy. Cancer Treat. Rev., 35, 1-8.
27. Rotenberg, S.A. et al. (1995) Deletion analysis of protein kinase C inactivation by calphostin C. Mol. Carcinog., 12, 42-49.
28. Masur, K. et al. (2001) High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells. Mol. Biol. Cell, 12, 1973-1982.
29. Jane, E.P. et al. (2006) Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells. J. Pharmacol. Exp. Ther., 319, 1070-1080.
30. Toullec, D. et al. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem., 266, 15771-15781.
31. Bellon, G. et al. (1985) Immunohistochemical localisation of macromolecules of the basement membrane and extracellular matrix of human gliomas and meningiomas. Acta Neuropathol., 66, 245-252.
32. Paulus, W. et al. (1988) Immunohistochemical investigation of collagen subtypes in human glioblastomas. Virchows Arch. A Pathol. Anat. Histopathol., 413, 325-332.
33. Besson, A. et al. (2002) The anchoring protein RACK1 links protein kinase Cepsilon to integrin beta chains. Requirements for adhesion and motility. J. Biol. Chem., 277, 22073-22084.
34. Besson, A. et al. (2001) Differential activation of ERKs to focal adhesions by PKC epsilon is required for PMA-induced adhesion and migration of human glioma cells. Oncogene, 20, 7398-7407.
35. Liao, Y.F. et al. (2005) The PKC delta inhibitor, rottlerin, induces apoptosis of haematopoietic cell lines through mitochondrial membrane depolarization and caspases' cascade. Life Sci., 77, 707-719.
36. Behrem, S. et al. (2005) Distribution pattern of tenascin-C in glioblastoma: correlation with angiogenesis and tumor cell proliferation. Pathol. Oncol. Res., 11, 229-235.
37. Lee, Y.S. et al. (1987) Comparison of monoclonal antibody delivery to intracranial glioma xenografts by intravenous and intracarotid administration. Cancer Res., 47, 1941-1946.
38. Lee, Y.S. et al. (1988) Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model. Cancer Res., 48, 559-566.
39. Reardon, D.A. et al. (2008) A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost. Neuro. Oncol., 10, 182-189.
40. Zukiel, R. et al. (2006) Suppression of human brain tumor with interference RNA specific for tenascin-C. Cancer Biol. Ther., 5, 1002-1007.
41. Ziu, M. et al. (2006) Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells. J. Neurooncol., 79, 125-133.
42. Guo, H. et al. (2009) Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells. J. Neurochem., 109, 203-213.
43. Baldwin, R.M. et al. (2008) Regulation of glioblastoma cell invasion by PKC iota and RhoB. Oncogene, 27, 3587-3595.
44. Amos, S. et al. (2007) Protein kinase C-alpha-mediated regulation of lowdensity lipoprotein receptor related protein and urokinase increases astrocytoma invasion. Cancer Res., 67, 10241-10251.
45. Griner, E.M. et al. (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer, 7, 281-294.
46. Alonso-Escolano, D. et al. (2006) Protein kinase C delta mediates plateletinduced breast cancer cell invasion. J. Pharmacol. Exp. Ther., 318, 373-380.
47. Lin, C.W. et al. (2008) Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis, 29, 1807-1815.
48. Mackay, H.J. et al. (2007) Targeting the protein kinase C family: are we there yet? Nat. Rev. Cancer, 7, 554-562.
49. Kreisl, T.N. et al. (2009) A phase I trial of enzastaurin in patients with recurrent gliomas. Clin. Cancer Res., 15, 3617-3623.